Renato DeRita, MS

IAGS (International Andreas Gruentzig Society) Proceedings

08/01/2008

First of all, I would like to thank the organizers of this meeting, particularly Dr. Michael Cowley, who asked me to attend. It’s an honor to be here. As a biochemist who has spent most of his life with his head in the “cell-culture”...

First of all, I would like to...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Industry Round Table: Where Are the New Drugs? (IAGS 2004)

08/01/2008

Scott Byrd ;

Philip Reid ;

John David Spencer , MD;

Renato DeRita , MS;

Mike Cowley , MD;

Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....

Philip Reid (Eli Lilly &...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Stroke Prevention and Therapies

08/01/2008

Renato DeRita , MS;

Barry S. George , MD, FACC, FSCAI;

Fayaz Shawl , MD;

Christopher U. Cates , MD;

Michael R. Mooney , MD;

Jiri J. Vitek , MD, PhD;

Norberto Schechtmann , MD;

Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...

Barry George: Needless to say,...

08/01/2008

Journal of Invasive Cardiology